Precigen Inc PGEN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
1.40UNCH (UNCH)
Volume
8,254
Close
1.40quote price arrow down-0.04 (-2.78%)
Volume
730,144
52 week range
0.84 - 1.88
Loading...
  • Open1.44
  • Day High1.49
  • Day Low1.39
  • Prev Close1.44
  • 52 Week High1.88
  • 52 Week High Date08/30/23
  • 52 Week Low0.84
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap353.388M
  • Shares Out252.42M
  • 10 Day Average Volume0.82M
  • Dividend-
  • Dividend Yield-
  • Beta1.88
  • YTD % Change4.85

KEY STATS

  • Open1.44
  • Day High1.49
  • Day Low1.39
  • Prev Close1.44
  • 52 Week High1.88
  • 52 Week High Date08/30/23
  • 52 Week Low0.84
  • 52 Week Low Date11/13/23
  • Market Cap353.388M
  • Shares Out252.42M
  • 10 Day Average Volume0.82M
  • Dividend-
  • Dividend Yield-
  • Beta1.88
  • YTD % Change4.85

RATIOS/PROFITABILITY

  • EPS (TTM)-0.39
  • P/E (TTM)-3.56
  • Fwd P/E (NTM)-4.02
  • EBITDA (TTM)-82.255M
  • ROE (TTM)-78.37%
  • Revenue (TTM)6.225M
  • Gross Margin (TTM)1.70%
  • Net Margin (TTM)-1,540.63%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Precigen Inc

 

Profile

MORE
Precigen, Inc. is a dedicated discovery and clinical-stage biopharmaceutical company advancing gene and cell therapies. The Company’s proprietary technology platforms develops product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders and infectious diseases. It has developed a pipeline of therapies across multiple indications. The Company operates through two segments: Biopharmaceuticals and...
Randal Kirk
Executive Chairman of the Board
Helen Sabzevari Ph.D.
President, Chief Executive Officer, Director; President of PGEN Therapeutics, Inc.
Rutul Shah
Chief Operating Officer
Harry Thomasian Jr.
Chief Financial Officer
Address
20374 SENECA MEADOWS PARKWAY
Germantown, MD
20876
United States

Top Peers

SYMBOLLASTCHG%CHG
XOMA
XOMA Corp
25.66+0.95+3.84%
ERAS
Erasca Inc
1.85-0.04-2.12%
AVXL
Anavex Life Sciences Corp
4.50+0.01+0.22%
ATAI
ATAI Life Sciences NV
1.86-0.19-9.27%
AVIR
Atea Pharmaceuticals Inc
3.70-0.01-0.27%